Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

Clinical trial NCT06304168 · RECRUITING

Trial details

NCT number: NCT06304168
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Start date: 2019-05-13
Primary completion: 2028-05-15
Enrollment: 6150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.